Ribavirin for Lassa Fever Postexposure Prophylaxis
نویسندگان
چکیده
منابع مشابه
Ribavirin for Lassa Fever Postexposure Prophylaxis
Vito Martella, Alessandro Bianchi, Irene Bertoletti, Luca Pedrotti, Alessandro Gugiatti, Alessia Catella, Paolo Cordioli, Maria S. Lucente, Gabriella Elia, and Canio Buonavoglia Author affi liations: Università di Bari, Bari, Italy (V. Martella, M.S. Lucente, G. Elia, C. Buonavoglia); Istituto Zooprofi lattico Sperimentale della Lombardia e dell’Emilia Romagna, Sezione di Sondrio, Italy (A. Bia...
متن کاملExperience with Ribavirin for Treatment and Postexposure Prophylaxis of Hemorrhagic Fever Viruses: Crimean Congo Hemorrhagic Fever, Lassa Fever, and Hantaviruses
Objectives: The decontamination or physical removal of contaminants from personal protective equipment upon exit from high containment laboratories is crucial to maintain containment and safety of laboratory workers. The current methodology for exiting from high-containment level 4 (CL-4) laboratory calls for laboratory personnel to decontaminate their worn positive pressure suits via “mechanic...
متن کاملReview of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.
Lassa fever is an acute viral hemorrhagic illness; the virus is endemic in West Africa and also of concern with regard to bioterrorism. Transmission of Lassa virus between humans may occur through direct contact with infected blood or bodily secretions. Oral administration of the antiviral drug ribavirin is often considered for postexposure prophylaxis, but no systematically collected data or u...
متن کاملRibavirin prophylaxis and therapy for experimental argentine hemorrhagic fever.
Junin virus-infected rhesus macaques received prophylactic and therapeutic ribavirin to assess the potential of this drug for treating humans with Argentine hemorrhagic fever. When ribavirin was administered intramuscularly at the time of experimental infection with the lethal P3790 strain of Junin virus, all animals were protected from clinical disease. A delay in the initiation of therapy unt...
متن کاملPathogenesis of Lassa Fever
Lassa virus, an Old World arenavirus (family Arenaviridae), is the etiological agent of Lassa fever, a severe human disease that is reported in more than 100,000 patients annually in the endemic regions of West Africa with mortality rates for hospitalized patients varying between 5-10%. Currently, there are no approved vaccines against Lassa fever for use in humans. Here, we review the publishe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Emerging Infectious Diseases
سال: 2010
ISSN: 1080-6040,1080-6059
DOI: 10.3201/eid1612.100994